Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Rizzi

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic ToxicityRamona Meanti, Laura Rizzi, Elena Bresciani, et al.
Nanoscale|July 15, 2015
Suspended monolayer graphene under true uniaxial deformationIoannis Polyzos, Massimiliano Bianchi, Laura Rizzi, et al.
Parkinsonism & Related Disorders|February 12, 2013
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movementsAristide Merola, Maurizio Zibetti, Carlo Alberto Artusi, et al.
International Journal of Molecular Sciences|January 21, 2023
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated ProteinRamona Meanti, Martina Licata, Laura Rizzi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2013
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?Aristide Merola, Laura Rizzi, Maurizio Zibetti, et al.
Epidemiologia E Prevenzione|January 8, 2021
Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysisMichele Gobbato, Elena Clagnan, Ivana Burba, et al.
Parkinsonism & Related Disorders|June 11, 2015
Earlier versus later subthalamic deep brain stimulation in Parkinson's diseaseAristide Merola, Alberto Romagnolo, Andrea Bernardini, et al.
Journal of Neurology|June 23, 2014
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patientsAristide Merola, Laura Rizzi, Carlo Alberto Artusi, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Anti-Inflammatory Effects of Progesterone on Human Microglia via TLR4/NLRP3 Pathway Modulation: Relevance to Drug-Resistant EpilepsyRamona Meanti, Maria Laura Criscione, Emma Sartori, et al.
Brain : a Journal of Neurology|June 14, 2011
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patientsAristide Merola, Maurizio Zibetti, Serena Angrisano, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic ToxicityRamona Meanti, Laura Rizzi, Elena Bresciani, et al.
Nanoscale|July 15, 2015
Suspended monolayer graphene under true uniaxial deformationIoannis Polyzos, Massimiliano Bianchi, Laura Rizzi, et al.
Parkinsonism & Related Disorders|February 12, 2013
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movementsAristide Merola, Maurizio Zibetti, Carlo Alberto Artusi, et al.
International Journal of Molecular Sciences|January 21, 2023
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated ProteinRamona Meanti, Martina Licata, Laura Rizzi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 13, 2013
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?Aristide Merola, Laura Rizzi, Maurizio Zibetti, et al.
Epidemiologia E Prevenzione|January 8, 2021
Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysisMichele Gobbato, Elena Clagnan, Ivana Burba, et al.
Parkinsonism & Related Disorders|June 11, 2015
Earlier versus later subthalamic deep brain stimulation in Parkinson's diseaseAristide Merola, Alberto Romagnolo, Andrea Bernardini, et al.
Journal of Neurology|June 23, 2014
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patientsAristide Merola, Laura Rizzi, Carlo Alberto Artusi, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Anti-Inflammatory Effects of Progesterone on Human Microglia via TLR4/NLRP3 Pathway Modulation: Relevance to Drug-Resistant EpilepsyRamona Meanti, Maria Laura Criscione, Emma Sartori, et al.
Brain : a Journal of Neurology|June 14, 2011
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patientsAristide Merola, Maurizio Zibetti, Serena Angrisano, et al.
Pageof 8